In terms of market side, this report researches the Cell Therapy revenue, growth rate, market share by manufacturers, by type, by application and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

The global Cell Therapy market size in 2023 is 5600.0 million US dollars, and it is expected to be 16706.7 million US dollars by 2030, with a compound annual growth rate of 16.9% expected in 2024-2030.

MARKET COMPETITIVE LANDSCAPE:
The main players in the Cell Therapy market include Novartis AG, Gilead Sciences, Inc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc, and JCR Pharmaceuticals Co., Ltd.. The share of the top 3 players in the Cell Therapy market is XX%.

REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Cell Therapy market, and Asia Pacific accounted for XX%.

SEGMENT OVERVIEW:
The report segments the market by Type and Application. Allogeneic Therapies accounted for XX% of Cell Therapy market in 2023. Autologous Therapies share of XX%.
Oncology accounted for XX% of the Cell Therapy market in 2023. Cardiovascular Disease (CVD) accounts for XX%.

Report Includes:
This report presents an overview of global market for Cell Therapy . Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key players of Cell Therapy , also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Cell Therapy , and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Therapy market share and industry ranking of main players, data from 2019 to 2024. Identification of the major stakeholders in the global Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, from 2019 to 2030. Evaluation and forecast the market size for Cell Therapy sales, projected growth trends, technology, application and end-user industry.

Chapter Outline
Chapter 1: Introduces the product overview, research purposes, and then includes economic analysis of global regions, inflation analysis, and the impact of the Russian-Ukrainian war on the market.
Chapter 2: Analysis of the competitive environment of Cell Therapy market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and expansion in recent years.
Chapters 3-5: Segmented the global Cell Therapy market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapter 6: Analyzes the main companies in the Cell Therapy industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 7: Analyzes the Cell Therapy business cost, including industrial chain and the proportion of business cost structure.
Chapter 8: Introduces the market dynamics, the trends factors and drivers factors of the market, and the challenges and restraints faced by manufacturers in the industry.
Chapters 9-10: Provide detailed Cell Therapy market forecast data, broken down by type, application, and region to help understand future growth trends.
Chapter 11: The main points and conclusions of the report.

Highlights-Regions

North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
EMEA
Europe
Germany
France
UK
Italy
Russia
Nordic
Middle East
Africa
Latin America
Brazil
Argentina
Mexico

Player list
Novartis AG
Gilead Sciences, Inc.
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc
JCR Pharmaceuticals Co., Ltd.
Tego Science
Atara Biotherapeutics
Takeda Pharmaceutical Company Limited
Bluebird Bio, Inc.
Dendreon Corp.

Types list
Allogeneic Therapies
Autologous Therapies

Application list
Oncology
Cardiovascular Disease (CVD)
Musculoskeletal Disorders

Table of Content

1 Cell Therapy Market Introduction and Overview
1.1 Cell Therapy Definition
1.2 Research Purposes
1.3 Currency Rate
1.4 Report Timeline
1.5 Economic Analysis of Global Regions
1.6 Inflation Analysis
1.7 The Impact of the Russian-Ukrainian War on the Market
2 Market Competition by Manufacturers
2.1 Global Cell Therapy Revenue and Market Share by Manufacturer
2.2 Manufacturers Cell Therapy Production Sites, Area Served, Product Types
2.3 Cell Therapy Market Competitive Situation and Trends
2.3.1 Cell Therapy Market Concentration Rate
2.3.2 Global Top 5 and Top 10 Players Market Share by Revenue in 2024
2.3.3 Mergers & Acquisitions, Expansion
3 Global Cell Therapy Historical Market Analysis by Type
3.1 Market Size Analysis by Types
3.1.4 Global Cell Therapy Market Share by Type 2019 VS 2023
3.2 Global Cell Therapy Revenue and Market Share by Type
4 Global Cell Therapy Historical and Forecast Market Analysis by Application
4.1 Market Size Analysis by Application
4.1.4 Global Cell Therapy Market Share by Application 2019 VS 2023
4.2 Global Cell Therapy Revenue Market Share by Application (2019-2024)
5 Global Market Growth Trends Analysis
5.1 Global Cell Therapy Market Size (2019-2024)
5.2 Cell Therapy Growth Trends Analysis by Regions
5.2.1 Cell Therapy Market Size by Regions: 2019 VS 2024 VS 2030
5.2.2 Cell Therapy Historic Revenue Market Size by Regions (2019-2024)
5.3 North America
5.3.1 North America Cell Therapy Revenue by Countries (2019-2024)
5.3.2 North America SWOT Analysis
5.3.3 United States
5.3.4 Canada
5.4 China
5.4.1 China SWOT Analysis
5.5 Asia Pacific (Excluding China)
5.5.1 Asia Pacific Cell Therapy Revenue by Countries (2019-2024)
5.5.2 Asia Pacific SWOT Analysis
5.5.3 Japan
5.5.4 Korea
5.5.5 Southeast Asia
5.5.6 India
5.5.7 Australia
5.6 EMEA
5.6.1 EMEA Cell Therapy Revenue by Countries (2019-2024)
5.6.2 EMEA SWOT Analysis
5.6.3 Europe
5.6.4 Middle East
5.6.5 Africa
5.7 Latin America
5.7.1 Latin America Cell Therapy Revenue by Countries (2019-2024)
5.7.2 Latin America SWOT Analysis
5.7.3 Brazil
5.7.4 Argentina
5.7.5 Mexico
6 Players Profiles
6.1 Novartis AG
6.1.1 Novartis AG Company Profile
6.1.2 Cell Therapy Product Overview
6.1.3 Novartis AG Cell Therapy Market Performance (2019-2024)
6.1.4 Novartis AG Business Overview
6.1.5 SWOT Analysis
6.2 Gilead Sciences, Inc.
6.2.1 Gilead Sciences, Inc. Company Profile
6.2.2 Cell Therapy Product Overview
6.2.3 Gilead Sciences, Inc. Cell Therapy Market Performance (2019-2024)
6.2.4 Gilead Sciences, Inc. Business Overview
6.2.5 SWOT Analysis
6.3 Bristol-Myers Squibb Company
6.3.1 Bristol-Myers Squibb Company Company Profile
6.3.2 Cell Therapy Product Overview
6.3.3 Bristol-Myers Squibb Company Cell Therapy Market Performance (2019-2024)
6.3.4 Bristol-Myers Squibb Company Business Overview
6.3.5 SWOT Analysis
6.4 Johnson & Johnson Services, Inc
6.4.1 Johnson & Johnson Services, Inc Company Profile
6.4.2 Cell Therapy Product Overview
6.4.3 Johnson & Johnson Services, Inc Cell Therapy Market Performance (2019-2024)
6.4.4 Johnson & Johnson Services, Inc Business Overview
6.4.5 SWOT Analysis
6.5 JCR Pharmaceuticals Co., Ltd.
6.5.1 JCR Pharmaceuticals Co., Ltd. Company Profile
6.5.2 Cell Therapy Product Overview
6.5.3 JCR Pharmaceuticals Co., Ltd. Cell Therapy Market Performance (2019-2024)
6.5.4 JCR Pharmaceuticals Co., Ltd. Business Overview
6.5.5 SWOT Analysis
6.6 Tego Science
6.6.1 Tego Science Company Profile
6.6.2 Cell Therapy Product Overview
6.6.3 Tego Science Cell Therapy Market Performance (2019-2024)
6.6.4 Tego Science Business Overview
6.6.5 SWOT Analysis
6.7 Atara Biotherapeutics
6.7.1 Atara Biotherapeutics Company Profile
6.7.2 Cell Therapy Product Overview
6.7.3 Atara Biotherapeutics Cell Therapy Market Performance (2019-2024)
6.7.4 Atara Biotherapeutics Business Overview
6.7.5 SWOT Analysis
6.8 Takeda Pharmaceutical Company Limited
6.8.1 Takeda Pharmaceutical Company Limited Company Profile
6.8.2 Cell Therapy Product Overview
6.8.3 Takeda Pharmaceutical Company Limited Cell Therapy Market Performance (2019-2024)
6.8.4 Takeda Pharmaceutical Company Limited Business Overview
6.8.5 SWOT Analysis
6.9 Bluebird Bio, Inc.
6.9.1 Bluebird Bio, Inc. Company Profile
6.9.2 Cell Therapy Product Overview
6.9.3 Bluebird Bio, Inc. Cell Therapy Market Performance (2019-2024)
6.9.4 Bluebird Bio, Inc. Business Overview
6.9.5 SWOT Analysis
6.10 Dendreon Corp.
6.10.1 Dendreon Corp. Company Profile
6.10.2 Cell Therapy Product Overview
6.10.3 Dendreon Corp. Cell Therapy Market Performance (2019-2024)
6.10.4 Dendreon Corp. Business Overview
6.10.5 SWOT Analysis
7 Cell Therapy Business Cost Analysis
7.1 Labor Cost Analysis
7.2 Proportion of Manufacturing Cost Structure
7.3 Cell Therapy Industrial Chain Analysis
8 Cell Therapy Industry Dynamic Analysis
8.1 Cell Therapy Market Trends Analysis
8.2 Cell Therapy Market Drivers Analysis
8.3 Cell Therapy Market Challenges Analysis
8.4 Cell Therapy Market Restraints Analysis
9 Global Cell Therapy Forecast Market Analysis by Type & Application
9.1 Global Cell Therapy Revenue Market Forecast by Type (2024-2030)
9.2 Cell Therapy Revenue Market Forecast by Application (2024-2030)
10 Global Cell Therapy Forecast Market Analysis by Region
10.1 Cell Therapy Revenue Market Forecast by Region (2024-2030)
10.2 North America Cell Therapy Forecast Market Analysis
10.3 EMEA Cell Therapy Forecast Market Analysis
10.4 China Cell Therapy Forecast Market Analysis
10.5 Asia-Pacific Cell Therapy Forecast Market Analysis
10.6 Latin America Cell Therapy Forecast Market Analysis
11 Research Findings and Conclusion

List of Tables and Figures

Figure Cell Therapy Picture
Table Product Definition of Cell Therapy
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Table Global Cell Therapy Revenue ($) by Manufacturer (2019-2024)
Table Global Cell Therapy Revenue Market Share by Manufacturer (2019-2024)
Figure Global Cell Therapy Revenue Market Share by Manufacturer in 2024
Table Manufacturers Cell Therapy Production Sites, Area Served, Product Types
Table Cell Therapy Market Concentration Rate
Figure Global Top 5 and Top 10 Players Market Share by Revenue in 2024
Table Mergers & Acquisitions, Expansion Plans
Table Global Cell Therapy Market Size by Type (2024 VS 2030)
Figure Global Cell Therapy Market Share by Type 2019 VS 2023
Table Global Cell Therapy Revenue and Market Size by Type (2019-2024)
Table Global Cell Therapy Revenue and Market Share by Type (2019-2024)
Table Global Cell Therapy Market Size by Application (2024 VS 2030)
Figure Global Cell Therapy Market Share by Application 2019 VS 2023
Table Global Cell Therapy Revenue Market Size by Application (2019-2024)
Table Global Cell Therapy Revenue Market Share by Application (2019-2024)
Figure Global Cell Therapy Revenue Market Size (2019-2024)
Table Cell Therapy Market Size by Regions: 2019 VS 2024 VS 2030
Table Cell Therapy Historic Revenue Market Size by Regions (2019-2024)
Table Cell Therapy Historic Revenue Market Share by Regions (2019-2024)
Figure North America Cell Therapy Revenue and Growth (2019-2024)
Table North America Cell Therapy Revenue by Countries (2019-2024)
Table North America Cell Therapy Revenue Market Share by Countries (2019-2024)
Table North America SWOT Analysis
Figure United States Cell Therapy Revenue and Growth (2019-2024)
Figure Canada Cell Therapy Revenue and Growth (2019-2024)
Table China SWOT Analysis
Figure China Cell Therapy Revenue and Growth (2019-2024)
Figure Asia Pacific Cell Therapy Revenue and Growth (2019-2024)
Table Asia-Pacific Cell Therapy Revenue by Countries (2019-2024)
Table Asia-Pacific Cell Therapy Revenue Market Share by Countries (2019-2024)
Table Asia Pacific SWOT Analysis
Figure Japan Cell Therapy Revenue and Growth (2019-2024)
Figure Korea Cell Therapy Revenue and Growth (2019-2024)
Figure Southeast Asia Cell Therapy Revenue and Growth (2019-2024)
Figure India Cell Therapy Revenue and Growth (2019-2024)
Figure Australia Cell Therapy Revenue and Growth (2019-2024)
Figure EMEA Cell Therapy Revenue and Growth (2019-2024)
Table EMEA Cell Therapy Revenue by Countries (2019-2024)
Table EMEA Cell Therapy Revenue Market Share by Countries (2019-2024)
Table EMEA SWOT Analysis
Figure Europe Cell Therapy Revenue and Growth (2019-2024)
Figure Germany Cell Therapy Revenue and Growth (2019-2030)
Figure France Cell Therapy Revenue and Growth (2019-2030)
Figure UK Cell Therapy Revenue and Growth (2019-2030)
Figure Italy Cell Therapy Revenue and Growth (2019-2030)
Figure Russia Cell Therapy Revenue and Growth (2019-2030)
Figure Nordic Cell Therapy Revenue and Growth (2019-2030)
Figure Middle East Cell Therapy Revenue and Growth (2019-2024)
Figure Africa Cell Therapy Revenue and Growth (2019-2024)
Figure Latin America Cell Therapy Revenue and Growth (2019-2024)
Table Latin America Cell Therapy Revenue by Countries (2019-2024)
Table Latin America Cell Therapy Revenue Market Share by Countries (2019-2024)
Table Latin America SWOT Analysis
Figure Brazil Cell Therapy Revenue and Growth (2019-2024)
Figure Argentina Cell Therapy Revenue and Growth (2019-2024)
Figure Mexico Cell Therapy Revenue and Growth (2019-2024)
Table Novartis AG Profile
Table Product Overview
Table Novartis AG Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Novartis AG Revenue and Growth Rate
Figure Novartis AG Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Gilead Sciences, Inc. Profile
Table Product Overview
Table Gilead Sciences, Inc. Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Gilead Sciences, Inc. Revenue and Growth Rate
Figure Gilead Sciences, Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Bristol-Myers Squibb Company Profile
Table Product Overview
Table Bristol-Myers Squibb Company Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Bristol-Myers Squibb Company Revenue and Growth Rate
Figure Bristol-Myers Squibb Company Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Johnson & Johnson Services, Inc Profile
Table Product Overview
Table Johnson & Johnson Services, Inc Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Johnson & Johnson Services, Inc Revenue and Growth Rate
Figure Johnson & Johnson Services, Inc Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table JCR Pharmaceuticals Co., Ltd. Profile
Table Product Overview
Table JCR Pharmaceuticals Co., Ltd. Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure JCR Pharmaceuticals Co., Ltd. Revenue and Growth Rate
Figure JCR Pharmaceuticals Co., Ltd. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Tego Science Profile
Table Product Overview
Table Tego Science Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Tego Science Revenue and Growth Rate
Figure Tego Science Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Atara Biotherapeutics Profile
Table Product Overview
Table Atara Biotherapeutics Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Atara Biotherapeutics Revenue and Growth Rate
Figure Atara Biotherapeutics Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Takeda Pharmaceutical Company Limited Profile
Table Product Overview
Table Takeda Pharmaceutical Company Limited Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Takeda Pharmaceutical Company Limited Revenue and Growth Rate
Figure Takeda Pharmaceutical Company Limited Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Bluebird Bio, Inc. Profile
Table Product Overview
Table Bluebird Bio, Inc. Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Bluebird Bio, Inc. Revenue and Growth Rate
Figure Bluebird Bio, Inc. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Dendreon Corp. Profile
Table Product Overview
Table Dendreon Corp. Cell Therapy Revenue, Gross and Gross Margin (2019-2024)
Figure Dendreon Corp. Revenue and Growth Rate
Figure Dendreon Corp. Revenue Market Share 2019-2030
Table Business Overview
Table SWOT Analysis
Table Labor Cost Analysis
Figure Proportion of Manufacturing Cost Structure
Figure Cell Therapy Industrial Chain Analysis
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Table Global Cell Therapy Revenue Market Size Forecast by Type (2024-2030)
Table Global Cell Therapy Revenue Market Share Forecast by Type (2024-2030)
Table Global Cell Therapy Revenue Market Size by Application (2024-2030)
Table Global Cell Therapy Revenue Market Share by Application (2024-2030)
Table Global Cell Therapy Revenue Market Size by Region (2024-2030)
Table Global Cell Therapy Revenue Market Share by Region (2024-2030)
Figure North America Cell Therapy Forecast Revenue and Growth 2024-2030
Figure EMEA Cell Therapy Forecast Revenue and Growth 2024-2030
Figure China Cell Therapy Forecast Revenue and Growth 2024-2030
Figure Asia-Pacific Cell Therapy Forecast Revenue and Growth 2024-2030
Figure Latin America Cell Therapy Forecast Revenue and Growth 2024-2030